ANI Pharmaceuticals, Inc. (ANIP) vs Harrow, Inc. (HROW)
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
- Harrow, Inc. HROW 27.28 −5.11%
ANI Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.7B against $1.1B — 1.5× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 14.9×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against 21.1%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs −13.5%) and the higher return on invested capital (11.3% vs −0.77%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 17 and Harrow, Inc. on 2.
Valuation
Profitability
| Metric | ANIP | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 73.28% | 53.94% |
| Operating margin | 15.37% | (1.00%) | 0.00% |
| Net margin | 11.04% | (13.51%) | 0.00% |
| Free cash flow margin | 17.12% | (4.75%) | 0.00% |
| Return on equity | 20.88% | (116.07%) | (0.40%) |
| Return on assets | 7.61% | (9.77%) | (3.32%) |
| Return on invested capital | 11.30% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack